Abdelaziz Toumi, PhD; Senior Director, Head of Commercial Solutions Ibex™ Design & Develop

Noel Smith, PhD; Head of Immunology, Applied Protein Services

Advancing an innovative drug from late stage discovery into the clinic is the most-critical step in drug product development. While drug developers would like to gain as much information on the product as possible, the scientific focus must be on the drug design for optimal efficacy and safety at this stage.

This is when key decisions are made that have a long-term impact and pave the way for clinical and commercial manufacturing as well as the future supply chain. In this early phase, it is less about speed, and more important to focus on quality from the start. During this webinar, we will discuss and discover:

• What pitfalls to avoid in order to seamlessly advance a new drug from late stage discovery into clinic
• How to efficiently manage the manufacturing process
• Ways to reduce time into clinic and equip drug candidates with a robust CMC-package
• How to add value as you advance from one clinical phase to the next and are looking for investors and partners